Meet StriderDCT at OCT DACH 2026

We’re coming to Basel for the 9th Annual Outsourcing in Clinical Trials DACH. We’d love to meet you at booth 28b. Let us know about your upcoming study, and we’ll show you how AI-enabled digital clinical trials can simplify your workflow and improve efficiency.

About OCT DACH

OCT DACH is a two-day conference for people who plan and run clinical trials in Germany, Austria and Switzerland. This is its ninth year, and it takes place in Basel on 3–4 November 2026. The 2026 event will focus on outsourcing strategies, sponsor-CRO collaboration, regulatory developments, AI in clinical trials, and patient engagement.

Why Visit StriderDCT?

We help pharma companies, biotechs, and CROs run digital and decentralized clinical trials. Patients find it easier to participate. Your teams find it easier to run.

We handle hybrid studies, virtual visits and fully decentralized trials. Our technology, clinical operations and patient engagement work together, so you get efficient execution and stay in control.

What Makes Us Different?

  • Proven DCT experience: We’ve supported 70+ decentralized clinical trials across therapeutic areas.
  • Lower trial costs: Cut trial costs by 20 to 30% with integrated technology and leaner operations.
  • Patient-centric execution: 100% patient satisfaction with our digital, patient-focused trial models.
  • Better data quality: Real-time eSource capture, remote monitoring and unified workflows give you clearer, better-quality data.
  • One integrated ecosystem: eSource, EDC, CTMS, eConsent, ePRO, eTMF, telemedicine and Mobile Research Nursing, all on one platform.
  • Integrated clinical operations: Our clinical operations team works alongside the technology to run your decentralized and hybrid trials smoothly.

Planning a study that could be more patient-friendly? Come talk to us at Booth 28b.

Meet Our Experts

Vijay Rajan

Pramila Coutinho